Literature DB >> 10510398

Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction.

E Lubberts1, L A Joosten, L van Den Bersselaar, M M Helsen, A C Bakker, J B van Meurs, F L Graham, C D Richards, W B van Den Berg.   

Abstract

Rheumatoid arthritis is a chronic inflammatory joint disease, leading to cartilage and bone destruction. In this study, we investigated the effects of local IL-4 application, introduced by a recombinant human type 5 adenovirus vector, in the knee joint of mice with collagen-induced arthritis. One intraarticular injection with an IL-4-expressing virus caused overexpression of IL-4 in the mouse knee joint. Enhanced onset and aggravation of the synovial inflammation were found in the IL-4 group. However, despite ongoing inflammation, histologic analysis showed impressive prevention of chondrocyte death and cartilage erosion. In line with this, chondrocyte proteoglycan synthesis was enhanced in the articular cartilage. This was quantified with ex vivo 35S-sulfate incorporation in patellar cartilage and confirmed by autoradiography on whole knee joint sections. Reduction of cartilage erosion was further substantiated by lack of expression of the stromelysin-dependent cartilage proteoglycan breakdown neoepitope VDIPEN in the Ad5E1 mIL-4-treated knee joint. Reduced metalloproteinase activity was also supported by markedly diminished mRNA expression of stromelysin-3 in the synovial tissue. Histologic analysis revealed marked reduction of polymorphonuclear cells in the synovial joint space in the IL-4-treated joints. This was confirmed by immunolocalization studies on knee joint sections using NIMP-R14 staining and diminished mRNA expression of macrophage-inflammatory protein-2 in the synovium tissue. mRNA levels of TNF-alpha and IL-1beta were suppressed as well, and IL-1beta and nitric oxide production by arthritic synovial tissue were strongly reduced. Our data show an impressive cartilage-protective effect of local IL-4 and underline the feasibility of local gene therapy with this cytokine in arthritis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10510398

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  38 in total

Review 1.  New therapies in development for autoimmune diseases: their rationale for combination treatment.

Authors:  V Strand
Journal:  Springer Semin Immunopathol       Date:  2001

2.  Overexpression of IL-17 in the knee joint of collagen type II immunized mice promotes collagen arthritis and aggravates joint destruction.

Authors:  E Lubberts; L A B Joosten; F A J van de Loo; P Schwarzenberger; J Kolls; W B van den Berg
Journal:  Inflamm Res       Date:  2002-02       Impact factor: 4.575

3.  Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis.

Authors:  Y Morita; J Yang; R Gupta; K Shimizu; E A Shelden; J Endres; J J Mulé; K T McDonagh; D A Fox
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

Review 4.  Anti-inflammatory strategies in cartilage repair.

Authors:  Ying Zhang; Tyler Pizzute; Ming Pei
Journal:  Tissue Eng Part B Rev       Date:  2014-06-23       Impact factor: 6.389

Review 5.  Arguments for interleukin 1 as a target in chronic arthritis.

Authors:  W B van den Berg
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

6.  Antibody-based delivery of IL4 to the neovasculature cures mice with arthritis.

Authors:  Teresa Hemmerle; Fabia Doll; Dario Neri
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

7.  Intra-articular gene delivery and expression of interleukin-1Ra mediated by self-complementary adeno-associated virus.

Authors:  Jesse D Kay; Elvire Gouze; Thomas J Oligino; Jean-Noel Gouze; Rachael S Watson; Padraic P Levings; Marsha L Bush; Anthony Dacanay; David M Nickerson; Paul D Robbins; Christopher H Evans; Steven C Ghivizzani
Journal:  J Gene Med       Date:  2009-07       Impact factor: 4.565

8.  Human immunodeficiency virus vector-mediated intra-articular expression of angiostatin inhibits progression of collagen-induced arthritis in mice.

Authors:  Ko Kato; Koichi Miyake; Tsutomu Igarashi; Shinichi Yoshino; Takashi Shimada
Journal:  Rheumatol Int       Date:  2004-06-15       Impact factor: 2.631

9.  IL-4 inhibition of IL-1 induced Matrix metalloproteinase-3 (MMP-3) expression in human fibroblasts involves decreased AP-1 activation via negative crosstalk involving of Jun N-terminal kinase (JNK).

Authors:  Mariah Chambers; Garrett Kirkpatrick; Michel Evans; Grzegorz Gorski; Sara Foster; Ruth C Borghaei
Journal:  Exp Cell Res       Date:  2013-04-19       Impact factor: 3.905

10.  IL-4 deficiency decreases mortality but increases severity of arthritis in experimental group B Streptococcus infection.

Authors:  Luciana Tissi; Francesco Bistoni; Manuela Puliti
Journal:  Mediators Inflamm       Date:  2009-07-07       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.